http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004117152-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_338209e62a2b0c980ba7c67789c011af |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-483 |
| filingDate | 2002-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60063f36f35e1fe27047da0c8f22c971 |
| publicationDate | 2004-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004117152-A |
| titleOfInvention | Activated platelet testing equipment |
| abstract | An object of the present invention is to provide a method capable of testing activated platelets having excellent sensitivity and specificity. Kind Code: A1 Abstract: Glycoproteins such as GPIIb / IIIa and P-selectin on the platelet surface, which appear with the activation of platelets, and phosphatidylserine, which is one of phospholipids, are specific to these substances. The method of detection using a binding ligand and the test of activated platelets by measuring platelets of a sample using citrate as an anticoagulant in a blood analyzer commonly used in clinical laboratories were combined. [Selection diagram] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012008044-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016537648-A |
| priorityDate | 2002-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.